GLP-1 Obesity Drugs · EP 1 · Jul 8, 2026
GLP-1 Drugs: What's Actually Better for Your Heart?
This week in GLP-1 Obesity Drugs
Papers covered
- Tirzepatide beats GLP-1s for heartdoi:10.1111/dom.71051
- Novel agonist-antagonist beats tirzepatidedoi:10.1111/dom.70967
- GLP-1 drugs: full cardiovascular storydoi:10.1161/circulationaha.126.079319
- Tirzepatide works in Type 1 diabetesdoi:10.1111/dom.71080
- CagriSema beats all rivals in meta-analysisdoi:10.1002/edm2.70248
Your field, every week
Get this for your own field.
Sciport turns the newest papers in your corner of the literature into a short weekly video like this one — auto-curated, delivered to your inbox. First episode’s on us.
Generate your first video →